Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
   Serine/threonine kinases
   Receptor serine/threonine kinases (RSTK)
   Receptor tyrosine kinases (RTK)
   Non-receptor tyrosine kinases
     SRC family
     ABL family
     SYK family
     JAK family
     FAK family
     Tec family
       BTK [HSA:695] [KO:K07370]
         D10223  Ibrutinib (JAN/USAN) <JP/US>
         D10893  Acalabrutinib (JAN/USAN/INN) <US>
         D11720  Acalabrutinib maleate (USAN)
         D10730  Spebrutinib (USAN/INN)
         D10731  Spebrutinib besylate (USAN)
         D11070  Tirabrutinib hydrochloride (JAN) <JP>
         D11422  Zanubrutinib (USAN/INN) <US>
         D11428  Vecabrutinib (USAN/INN)
         D11457  Fenebrutinib (USAN/INN)
         D11478  Branebrutinib (USAN)
         D11502  Vecabrutinib succinate (USAN)
 
 
 
 
 
 
 
 
 
 
 
     InsR family
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 11, 2020

» Japanese version